![W. Mullally](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
W. Mullally
Direktor/Vorstandsmitglied bei THIOGENESIS THERAPEUTICS, CORP.
Vermögen: 448 875 $ am 31.05.2024
Aktive Positionen von W. Mullally
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
THIOGENESIS THERAPEUTICS, CORP. | Direktor/Vorstandsmitglied | 03.05.2018 | - |
Independent Dir/Board Member | 03.05.2018 | - | |
Sectorspeak, Inc. | Gründer | 01.03.2008 | - |
Präsident | 01.03.2008 | - |
Karriereverlauf von W. Mullally
Ehemalige bekannte Positionen von W. Mullally
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ROZDIL CAPITAL CORPORATION | Direktor/Vorstandsmitglied | - | 18.04.2022 |
MEDICURE INC. | Public Communications Contact | 01.01.2005 | 01.01.2008 |
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Vertrieb & Marketing | 01.01.1999 | 01.01.2001 |
FUNCTIONAL TECHNOLOGIES CORP | Investor Relations Kontakt | 01.08.2011 | - |
Public Communications Contact | 14.05.2008 | - |
Ausbildung von W. Mullally
Asper School of Business | Masters Business Admin |
Statistik
International
Kanada | 6 |
2 | |
Australien | 2 |
Operativ
Director/Board Member | 2 |
Public Communications Contact | 2 |
Founder | 1 |
Sektoral
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDICURE INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Rozdil Capital Corp.
![]() Rozdil Capital Corp. Financial ConglomeratesFinance Rozdil Capital Corp. operates as a capital pool company. It is engaged in the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada. | Finance |
Sectorspeak, Inc. | |
Thiogenesis Therapeutics Corp. | |
Functional Technologies Corp.
![]() Functional Technologies Corp. Food: Major DiversifiedConsumer Non-Durables Functional Technologies Corp. develops and commercializes proprietary, yeast-based solutions in the food, beverage and healthcare industries. Its technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide and carcinogen and acrylamide, both by-products of food and beverage processing. The company was founded by Howard J. Louie and Geoffrey Conrad Lee on October 18, 1999 and is headquartered in Vancouver, Canada. | Consumer Non-Durables |
Bausch & Lomb (Australia) Pty Ltd.
![]() Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Health Technology |
- Börse
- Insiders
- W. Mullally
- Erfahrung